Brown Advisory Inc. Sells 44,215 Shares of Cardinal Health, Inc. $CAH

Brown Advisory Inc. decreased its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 25.3% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 130,647 shares of the company’s stock after selling 44,215 shares during the period. Brown Advisory Inc. owned 0.05% of Cardinal Health worth $21,949,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Norges Bank purchased a new stake in shares of Cardinal Health in the second quarter worth about $584,420,000. Wellington Management Group LLP lifted its stake in Cardinal Health by 1,666.7% in the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after purchasing an additional 2,249,241 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after purchasing an additional 1,193,983 shares during the period. Zurich Insurance Group Ltd FI boosted its holdings in Cardinal Health by 4,935.9% in the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock valued at $130,434,000 after purchasing an additional 927,950 shares during the period. Finally, Acadian Asset Management LLC grew its position in shares of Cardinal Health by 92.5% during the 2nd quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock valued at $282,063,000 after purchasing an additional 807,063 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

CAH opened at $198.93 on Friday. Cardinal Health, Inc. has a one year low of $114.60 and a one year high of $214.93. The business has a 50 day simple moving average of $182.59 and a two-hundred day simple moving average of $165.13. The firm has a market capitalization of $47.27 billion, a price-to-earnings ratio of 30.00, a PEG ratio of 1.45 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The business’s quarterly revenue was up 22.4% compared to the same quarter last year. During the same period last year, the company earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be given a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. Citigroup lifted their price objective on Cardinal Health from $165.00 to $190.00 and gave the company a “neutral” rating in a research note on Friday, October 31st. Morgan Stanley reiterated an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Mizuho upped their price objective on shares of Cardinal Health from $170.00 to $210.00 and gave the stock an “outperform” rating in a research report on Monday, November 3rd. Leerink Partners raised their target price on shares of Cardinal Health from $211.00 to $230.00 and gave the company an “outperform” rating in a research note on Monday, November 17th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and an average price target of $206.57.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.